149 related articles for article (PubMed ID: 34721544)
1. Agent Repurposing for the Treatment of Advanced Stage Diffuse Large B-Cell Lymphoma Based on Gene Expression and Network Perturbation Analysis.
Xiang C; Ni H; Wang Z; Ji B; Wang B; Shi X; Wu W; Liu N; Gu Y; Ma D; Liu H
Front Genet; 2021; 12():756784. PubMed ID: 34721544
[TBL] [Abstract][Full Text] [Related]
2. Identification of ATP1B1, a key copy number driver gene in diffuse large B-cell lymphoma and potential target for drugs.
Zhang S; Wang H; Liu A
Ann Transl Med; 2022 Oct; 10(20):1136. PubMed ID: 36388804
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a five-gene signature associated with stromal infiltration for diffuse large B-cell lymphoma.
Nan YY; Zhang WJ; Huang DH; Li QY; Shi Y; Yang T; Liang XP; Xiao CY; Guo BL; Xiang Y
World J Clin Cases; 2021 Jun; 9(18):4585-4598. PubMed ID: 34222425
[TBL] [Abstract][Full Text] [Related]
4. Identification of hub genes associated with the pathogenesis of diffuse large B-cell lymphoma subtype one characterized by host response via integrated bioinformatic analyses.
Zhou L; Ding L; Gong Y; Zhao J; Xin G; Zhou R; Zhang W
PeerJ; 2020; 8():e10269. PubMed ID: 33240622
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Luo B; Gu YY; Wang XD; Chen G; Peng ZG
Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential key genes associated with diffuse large B-cell lymphoma based on microarray gene expression profiling.
Luo X; Shi F; Qiu H; Tong Y; Gao X
Neoplasma; 2017; 64(6):824-833. PubMed ID: 28895406
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomics analysis of differentially expressed proteins in activated B-cell-like diffuse large B-cell lymphoma using quantitative proteomics.
Gao HX; Nuerlan A; Abulajiang G; Cui WL; Xue J; Sang W; Li SJ; Niu J; Ma ZP; Zhang W; Li XX
Pathol Res Pract; 2019 Sep; 215(9):152528. PubMed ID: 31324389
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive characterization of driver genes in diffuse large B cell lymphoma.
Fan Z; Pei R; Sha K; Chen L; Wang T; Lu Y
Oncol Lett; 2020 Jul; 20(1):382-390. PubMed ID: 32565964
[TBL] [Abstract][Full Text] [Related]
9. Potential Drug Prediction of Glioblastoma Based on Drug Perturbation-Induced Gene Expression Signatures.
Zhu B; Mao X; Man Y
Biomed Res Int; 2021; 2021():6659701. PubMed ID: 33575336
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients.
Zhao C; Huang R; Zeng Z; Yang S; Lu W; Liu J; Wei Y; Guo H; Zhang Y; Yan P; Huang Z; Shi J
Aging (Albany NY); 2021 May; 13(10):14131-14158. PubMed ID: 34001679
[TBL] [Abstract][Full Text] [Related]
11. Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma.
Li H; Yu L; Zhang X; Shang J; Duan X
Front Immunol; 2022; 13():1036239. PubMed ID: 36389761
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis reveals dynamic candidate genes and signaling pathways involved in the progression and prognosis of diffuse large B-cell lymphoma.
Charwudzi A; Meng Y; Hu L; Ding C; Pu L; Li Q; Xu M; Zhai Z; Xiong S
PeerJ; 2021; 9():e12394. PubMed ID: 34760386
[TBL] [Abstract][Full Text] [Related]
13. Identifying RBM47, HCK, CD53, TYROBP, and HAVCR2 as Hub Genes in Advanced Atherosclerotic Plaques by Network-Based Analysis and Validation.
Liu C; Zhang H; Chen Y; Wang S; Chen Z; Liu Z; Wang J
Front Genet; 2020; 11():602908. PubMed ID: 33519905
[No Abstract] [Full Text] [Related]
14. A Computational Framework to Identify Biomarkers for Glioma Recurrence and Potential Drugs Targeting Them.
Ma S; Guo Z; Wang B; Yang M; Yuan X; Ji B; Wu Y; Chen S
Front Genet; 2021; 12():832627. PubMed ID: 35116059
[No Abstract] [Full Text] [Related]
15. Clinical Features and Prognostic Impact of Coexpression Modules Constructed by WGCNA for Diffuse Large B-Cell Lymphoma.
Xiao J; Wang X; Bai H
Biomed Res Int; 2020; 2020():7947208. PubMed ID: 32596373
[TBL] [Abstract][Full Text] [Related]
16. Machine learning algorithms identify target genes and the molecular mechanism of matrine against diffuse large B-cell lymphoma.
Zhu Y; Ning Z; Li X; Lin Z
Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37605410
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma.
Sun C; Cheng X; Wang C; Wang X; Xia B; Zhang Y
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30393234
[TBL] [Abstract][Full Text] [Related]
18. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
19. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray.
Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX
Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857
[TBL] [Abstract][Full Text] [Related]
20. Identification of B-cell translocation gene 1-controlled gene networks in diffuse large B-cell lymphoma: A study based on bioinformatics analysis.
Yan W; Li SX; Gao H; Yang W
Oncol Lett; 2019 Mar; 17(3):2825-2835. PubMed ID: 30854058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]